BlackRock’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-41,677
| Closed | -$165K | – | 5554 |
|
|
2025
Q3 | $165K | Sell |
41,677
-2
| -0% | -$14 | ﹤0.01% | 4721 |
|
|
2025
Q2 | $500K | Sell |
41,679
-11,716
| -22% | -$145K | ﹤0.01% | 4438 |
|
|
2025
Q1 | $735K | Sell |
53,395
-5,115
| -9% | -$73.4K | ﹤0.01% | 4283 |
|
|
2024
Q4 | $834K | Buy |
58,510
+4,913
| +9% | +$80.8K | ﹤0.01% | 4267 |
|
|
2024
Q3 | $1.02M | Buy |
53,597
+388
| +0.7% | +$6.62K | ﹤0.01% | 4166 |
|
|
2024
Q2 | $1.04M | Buy |
53,209
+2,661
| +5% | +$51.4K | ﹤0.01% | 4168 |
|
|
2024
Q1 | $1.16M | Sell |
50,548
-102
| -0.2% | -$2.2K | ﹤0.01% | 4162 |
|
|
2023
Q4 | $889K | Sell |
50,650
-232
| -0.5% | -$3.31K | ﹤0.01% | 4294 |
|
|
2023
Q3 | $664K | Sell |
50,882
-3,339
| -6% | -$50.6K | ﹤0.01% | 4345 |
|
|
2023
Q2 | $911K | Buy |
54,221
+986
| +2% | +$17K | ﹤0.01% | 4315 |
|
|
2023
Q1 | $830K | Sell |
53,235
-45
| -0.1% | -$874 | ﹤0.01% | 4384 |
|
|
2022
Q4 | $895K | Sell |
53,280
-26,050
| -33% | -$469K | ﹤0.01% | 4441 |
|
|
2022
Q3 | $1.34M | Sell |
79,330
-1,536
| -2% | -$33.6K | ﹤0.01% | 4372 |
|
|
2022
Q2 | $1.78M | Sell |
80,866
-412
| -0.5% | -$10K | ﹤0.01% | 4296 |
|
|
2022
Q1 | $2.79M | Sell |
81,278
-15
| -0% | -$449 | ﹤0.01% | 4251 |
|
|
2021
Q4 | $3.35M | Buy |
81,293
+27,670
| +52% | +$1.79M | ﹤0.01% | 4181 |
|
|
2021
Q3 | $4.83M | Buy |
53,623
+2,186
| +4% | +$193K | ﹤0.01% | 3975 |
|
|
2021
Q2 | $3.76M | Sell |
51,437
-6,770
| -12% | -$315K | ﹤0.01% | 3999 |
|
|
2021
Q1 | $2.16M | Buy |
58,207
+7,196
| +14% | +$361K | ﹤0.01% | 4268 |
|
|
2020
Q4 | $2.1M | Buy |
51,011
+671
| +1% | +$17.4K | ﹤0.01% | 4029 |
|
|
2020
Q3 | $1.16M | Sell |
50,340
-72
| -0.1% | -$1.86K | ﹤0.01% | 4076 |
|
|
2020
Q2 | $1.42M | Sell |
50,412
-95
| -0.2% | -$2.8K | ﹤0.01% | 3936 |
|
|
2020
Q1 | $1.29M | Buy |
50,507
+510
| +1% | +$18.9K | ﹤0.01% | 3800 |
|
|
2019
Q4 | $2.17M | Buy |
49,997
+11,938
| +31% | +$251K | ﹤0.01% | 3760 |
|
|
2019
Q3 | $360K | Sell |
38,059
-348
| -0.9% | -$4.99K | ﹤0.01% | 4224 |
|
|
2019
Q2 | $560K | Sell |
38,407
-84,760
| -69% | -$1.51M | ﹤0.01% | 4167 |
|
|
2019
Q1 | $2.55M | Sell |
123,167
-3,686
| -3% | -$73.1K | ﹤0.01% | 3623 |
|
|
2018
Q4 | $2.04M | Sell |
126,853
-21
| -0% | -$985 | ﹤0.01% | 3656 |
|
|
2018
Q3 | $11.7M | Buy |
126,874
+2,877
| +2% | +$342K | ﹤0.01% | 3155 |
|
|
2018
Q2 | $19.9M | Buy |
123,997
+43,020
| +53% | +$7.25M | ﹤0.01% | 2855 |
|
|
2018
Q1 | $13M | Buy |
80,977
+15,435
| +24% | +$1.88M | ﹤0.01% | 2991 |
|
|
2017
Q4 | $6.88M | Sell |
65,542
-25,041
| -28% | -$2.69M | ﹤0.01% | 3322 |
|
|
2017
Q3 | $11.9M | Buy |
90,583
+3,807
| +4% | +$465K | ﹤0.01% | 3070 |
|
|
2017
Q2 | $11.9M | Buy |
86,776
+33,348
| +62% | +$4M | ﹤0.01% | 3073 |
|
|
2017
Q1 | $6.36M | Buy |
53,428
+53,291
| +38,899% | +$6.29M | ﹤0.01% | 3304 |
|
|
2016
Q4 | $18K | Buy |
+137
| New | +$34.4K | ﹤0.01% | 3277 |
|
Other funds holding CLSD
BlackRock's CLSD Position: Q4 2025 in Review
BlackRock sold out of Clearside Biomedical (CLSD) in Q4 2025, closing a stake of 41,677 shares — an estimated $165K sold.
BlackRock first reported a position in CLSD in Q4 2016 and held it in 36 quarters. The position peaked at $19.9M in Q2 2018. 1 fund tracked by Wall St. Rank holds CLSD as of Q4 2025.
- BlackRock reported no remaining Clearside Biomedical position as of Q4 2025 after selling out during the quarter.
- BlackRock sold 41,677 Clearside Biomedical shares in Q4 2025, an estimated $165K.
- BlackRock first reported a position in Clearside Biomedical in Q4 2016 and held it in 36 quarters.
- BlackRock's Clearside Biomedical position peaked at $19.9M in Q2 2018.
- 1 fund tracked by Wall St. Rank held Clearside Biomedical as of Q4 2025.
Based on BlackRock's 13F filing for Q4 2025, filed 12 Feb 2026.